CompletedNot Applicable

Distress, Anxiety and Psychosexual Health in BOT

Belgium60 participantsStarted 2020-09-01

Plain-language summary

The aim of this study is to assess the prevalence of distress, anxiety and psychosexual anguish in patients diagnosed with borderline ovarian tumor (BOT) compared to controls confronted with surgical treatment for benign ovarian tumors.

Who can participate

Age range18 Years – 100 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis and surgery for benign or borderline ovarian tumors. * \>18 y. Exclusion Criteria: * Known former psychological morbidity evaluated by the investigators. * History of another cancer type.

What they're measuring

Anxiety and Depression - HADS

Timeframe: 2020

Depression - BIS

Timeframe: 2020

Anxiety - Perceived Stress Scale

Timeframe: 2020

Psycho-sexual health - FSFI

Timeframe: 2020

Psycho-sexual health - FSDS - Revised

Timeframe: 2020

Psycho-sexual health - EORTC OV28

Timeframe: 2020

Psycho-sexual health - EORTC SHQ C22

Timeframe: 2020

Trial details

NCT IDNCT04253327

SponsorUniversitair Ziekenhuis Brussel

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-02-01

View on ClinicalTrials.gov More Ovarian Neoplasm Epithelial Borderline trials